David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$696M |
| 2 |
Apple
AAPL
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$289M |
| 4 |
Keurig Dr Pepper
KDP
|
+$275M |
| 5 |
Meta Platforms (Facebook)
META
|
+$241M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWX
Time Warner Inc
TWX
|
+$648M |
| 2 |
Merck
MRK
|
+$453M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$273M |
| 5 |
Broadcom
AVGO
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.15% |
| 2 | Consumer Discretionary | 12.62% |
| 3 | Healthcare | 10.65% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGL
2126
DELISTED
Engility Holdings, Inc.
EGL
| $2.16M | ﹤0.01% |
70,354
+5,905
| +9% | +$168K |
|
2127
CALL
Cardinal Health
CAH
$55.3B
| $2.15M | ﹤0.01% |
44,100
+9,100
| +26% | +$516K |
|
|
FFIC
2128
DELISTED
Flushing Financial
FFIC
| $2.15M | ﹤0.01% |
82,317
+57,768
| +235% | +$1.55M |
|
2129
ATN International
ATNI
$473M
| $2.14M | ﹤0.01% |
40,585
+10,541
| +35% | +$592K |
|
|
TYPE
2130
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $2.14M | ﹤0.01% |
105,532
+61,863
| +142% | +$1.36M |
|
|
RVNC
2131
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.14M | ﹤0.01% |
77,994
+68,706
| +740% | +$2.06M |
|
|
SEM
2132
DELISTED
Select Medical
SEM
| $2.14M | ﹤0.01% |
218,858
-93,245
| -30% | -$916K |
|
2133
CALL
International Paper
IP
$21.7B
| $2.13M | ﹤0.01% |
+43,296
| New | +$2.21M |
|
2134
Alexandria Real Estate Equities
ARE
$9.1B
| $2.13M | ﹤0.01% |
16,881
+83
| +0.5% | +$10.4K |
|
|
CPE
2135
DELISTED
Callon Petroleum Company
CPE
| $2.13M | ﹤0.01% |
19,827
-2,021
| -9% | -$251K |
|
2136
PUT
PG&E
PCG
$40.4B
| $2.13M | ﹤0.01% |
50,000
| – | – |
|
2137
Phunware
PHUN
$43.9M
| $2.13M | ﹤0.01% |
4,100
| – | – |
|
|
AVX
2138
DELISTED
AVX Corporation
AVX
| $2.13M | ﹤0.01% |
135,680
+82,950
| +157% | +$1.32M |
|
|
TSRO
2139
PUT
DELISTED
TESARO, Inc.
TSRO
| $2.13M | ﹤0.01% |
47,800
| – | – |
|
2140
Fluor
FLR
$6.86B
| $2.12M | ﹤0.01% |
43,548
-61,197
| -58% | -$3.2M |
|
|
PNK
2141
DELISTED
Pinnacle Entertainment Inc.
PNK
| $2.12M | ﹤0.01% |
62,951
-17,190
| -21% | -$561K |
|
2142
ASE Group
ASX
$96.5B
| $2.12M | ﹤0.01% |
460,773
+341,816
| +287% | +$1.88M |
|
2143
Rayonier
RYN
$6.32B
| $2.12M | ﹤0.01% |
60,399
+52,397
| +655% | +$1.79M |
|
2144
Dorman Products
DORM
$3.87B
| $2.12M | ﹤0.01% |
31,006
-12,488
| -29% | -$842K |
|
|
GRP.U
2145
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $2.11M | ﹤0.01% |
51,668
+9,300
| +22% | +$375K |
|
2146
American Express
AXP
$227B
| $2.11M | ﹤0.01% |
21,513
-75,440
| -78% | -$7.41M |
|
|
FL
2147
PUT
DELISTED
Foot Locker
FL
| $2.11M | ﹤0.01% |
40,000
-175,500
| -81% | -$8.49M |
|
2148
KBR
KBR
$4.75B
| $2.1M | ﹤0.01% |
117,422
-107,047
| -48% | -$1.86M |
|
2149
CALL
XPO
XPO
$22.5B
| $2.1M | ﹤0.01% |
60,719
+11,854
| +24% | +$430K |
|
2150
CALL
Abercrombie & Fitch
ANF
$4.84B
| $2.1M | ﹤0.01% |
85,900
+63,500
| +283% | +$1.66M |
|
Similar funds
David Shaw's Q2 2018 Portfolio in Review
As of Q2 2018, David Shaw held 4,066 positions worth $76.7B, up 4.4% from $73.5B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2018 filing shows 622 new, 1,512 increased, 1,263 reduced and 399 closed positions. Its largest new stake was Evergy: 4,161,679 shares worth $234M. The largest sale was Time Warner Inc, an estimated $648M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2018 buy was Evergy: 4,161,679 shares worth $234M.
- David Shaw added most to Amazon in Q2 2018, an estimated $696M increase.
- David Shaw's biggest Q2 2018 reduction was Merck, cutting an estimated $453M.
- David Shaw fully exited Time Warner Inc in Q2 2018, selling an estimated $648M.
- David Shaw's ten largest holdings make up 9.8% of its $76.7B portfolio in Q2 2018.
- David Shaw opened 622 new positions and closed 399 in Q2 2018.
- David Shaw's portfolio value rose 4.4% quarter-over-quarter to $76.7B.
Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.